Influenza Vaccine Market - Global Outlook and Forecast 2021-2027

Influenza Vaccine Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Influenza Vaccine Overall Market Size
2.1 Global Influenza Vaccine Market Size: 2021 VS 2027
2.2 Global Influenza Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Influenza Vaccine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Influenza Vaccine Players in Global Market
3.2 Top Global Influenza Vaccine Companies Ranked by Revenue
3.3 Global Influenza Vaccine Revenue by Companies
3.4 Global Influenza Vaccine Sales by Companies
3.5 Global Influenza Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Influenza Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Influenza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Influenza Vaccine Market Size Markets, 2021 & 2027
4.1.2 Whole Virus Vaccines
4.1.3 Split Virus Vaccines
4.1.4 Subunit Vaccines
4.1.5 Live Attenuated Virus Vaccines
4.2 By Type - Global Influenza Vaccine Revenue & Forecasts
4.2.1 By Type - Global Influenza Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Influenza Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Influenza Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Influenza Vaccine Sales & Forecasts
4.3.1 By Type - Global Influenza Vaccine Sales, 2016-2021
4.3.2 By Type - Global Influenza Vaccine Sales, 2022-2027
4.3.3 By Type - Global Influenza Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Influenza Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Influenza Vaccine Market Size, 2021 & 2027
5.1.2 For Children (6 months to 3 years)
5.1.3 For Adults and Children over 3 years
5.2 By Application - Global Influenza Vaccine Revenue & Forecasts
5.2.1 By Application - Global Influenza Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Influenza Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Influenza Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Influenza Vaccine Sales & Forecasts
5.3.1 By Application - Global Influenza Vaccine Sales, 2016-2021
5.3.2 By Application - Global Influenza Vaccine Sales, 2022-2027
5.3.3 By Application - Global Influenza Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Influenza Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Influenza Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Influenza Vaccine Revenue & Forecasts
6.2.1 By Region - Global Influenza Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Influenza Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Influenza Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Influenza Vaccine Sales & Forecasts
6.3.1 By Region - Global Influenza Vaccine Sales, 2016-2021
6.3.2 By Region - Global Influenza Vaccine Sales, 2022-2027
6.3.3 By Region - Global Influenza Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Influenza Vaccine Revenue, 2016-2027
6.4.2 By Country - North America Influenza Vaccine Sales, 2016-2027
6.4.3 US Influenza Vaccine Market Size, 2016-2027
6.4.4 Canada Influenza Vaccine Market Size, 2016-2027
6.4.5 Mexico Influenza Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Influenza Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe Influenza Vaccine Sales, 2016-2027
6.5.3 Germany Influenza Vaccine Market Size, 2016-2027
6.5.4 France Influenza Vaccine Market Size, 2016-2027
6.5.5 U.K. Influenza Vaccine Market Size, 2016-2027
6.5.6 Italy Influenza Vaccine Market Size, 2016-2027
6.5.7 Russia Influenza Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries Influenza Vaccine Market Size, 2016-2027
6.5.9 Benelux Influenza Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Influenza Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia Influenza Vaccine Sales, 2016-2027
6.6.3 China Influenza Vaccine Market Size, 2016-2027
6.6.4 Japan Influenza Vaccine Market Size, 2016-2027
6.6.5 South Korea Influenza Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia Influenza Vaccine Market Size, 2016-2027
6.6.7 India Influenza Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Influenza Vaccine Revenue, 2016-2027
6.7.2 By Country - South America Influenza Vaccine Sales, 2016-2027
6.7.3 Brazil Influenza Vaccine Market Size, 2016-2027
6.7.4 Argentina Influenza Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Influenza Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Influenza Vaccine Sales, 2016-2027
6.8.3 Turkey Influenza Vaccine Market Size, 2016-2027
6.8.4 Israel Influenza Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia Influenza Vaccine Market Size, 2016-2027
6.8.6 UAE Influenza Vaccine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 CSL
7.1.1 CSL Corporate Summary
7.1.2 CSL Business Overview
7.1.3 CSL Influenza Vaccine Major Product Offerings
7.1.4 CSL Influenza Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 CSL Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Influenza Vaccine Major Product Offerings
7.2.4 GSK Influenza Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 GSK Key News
7.3 Sanofi Pasteur
7.3.1 Sanofi Pasteur Corporate Summary
7.3.2 Sanofi Pasteur Business Overview
7.3.3 Sanofi Pasteur Influenza Vaccine Major Product Offerings
7.3.4 Sanofi Pasteur Influenza Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 Sanofi Pasteur Key News
7.4 Mylan
7.4.1 Mylan Corporate Summary
7.4.2 Mylan Business Overview
7.4.3 Mylan Influenza Vaccine Major Product Offerings
7.4.4 Mylan Influenza Vaccine Sales and Revenue in Global (2016-2021)
7.4.5 Mylan Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Influenza Vaccine Major Product Offerings
7.5.4 AstraZeneca Influenza Vaccine Sales and Revenue in Global (2016-2021)
7.5.5 AstraZeneca Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Influenza Vaccine Major Product Offerings
7.6.4 Pfizer Influenza Vaccine Sales and Revenue in Global (2016-2021)
7.6.5 Pfizer Key News
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Corporate Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Influenza Vaccine Major Product Offerings
7.4.4 Johnson & Johnson Influenza Vaccine Sales and Revenue in Global (2016-2021)
7.7.5 Johnson & Johnson Key News
8 Global Influenza Vaccine Production Capacity, Analysis
8.1 Global Influenza Vaccine Production Capacity, 2016-2027
8.2 Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Influenza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Influenza Vaccine Supply Chain Analysis
10.1 Influenza Vaccine Industry Value Chain
10.2 Influenza Vaccine Upstream Market
10.3 Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Influenza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Influenza Vaccine in Global Market
Table 2. Top Influenza Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Influenza Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Influenza Vaccine Revenue Share by Companies, 2016-2021
Table 5. Global Influenza Vaccine Sales by Companies, (K Doses), 2016-2021
Table 6. Global Influenza Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Influenza Vaccine Price (2016-2021) & (USD/Doses)
Table 8. Global Manufacturers Influenza Vaccine Product Type
Table 9. List of Global Tier 1 Influenza Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Influenza Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Influenza Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Influenza Vaccine Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Influenza Vaccine Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Influenza Vaccine Sales (K Doses), 2016-2021
Table 15. By Type - Global Influenza Vaccine Sales (K Doses), 2022-2027
Table 16. By Application - Global Influenza Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Influenza Vaccine Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Influenza Vaccine Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Influenza Vaccine Sales (K Doses), 2016-2021
Table 20. By Application - Global Influenza Vaccine Sales (K Doses), 2022-2027
Table 21. By Region - Global Influenza Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Influenza Vaccine Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Influenza Vaccine Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Influenza Vaccine Sales (K Doses), 2016-2021
Table 25. By Region - Global Influenza Vaccine Sales (K Doses), 2022-2027
Table 26. By Country - North America Influenza Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Influenza Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Influenza Vaccine Sales, (K Doses), 2016-2021
Table 29. By Country - North America Influenza Vaccine Sales, (K Doses), 2022-2027
Table 30. By Country - Europe Influenza Vaccine Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Influenza Vaccine Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Influenza Vaccine Sales, (K Doses), 2016-2021
Table 33. By Country - Europe Influenza Vaccine Sales, (K Doses), 2022-2027
Table 34. By Region - Asia Influenza Vaccine Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Influenza Vaccine Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Influenza Vaccine Sales, (K Doses), 2016-2021
Table 37. By Region - Asia Influenza Vaccine Sales, (K Doses), 2022-2027
Table 38. By Country - South America Influenza Vaccine Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Influenza Vaccine Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Influenza Vaccine Sales, (K Doses), 2016-2021
Table 41. By Country - South America Influenza Vaccine Sales, (K Doses), 2022-2027
Table 42. By Country - Middle East & Africa Influenza Vaccine Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Influenza Vaccine Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Influenza Vaccine Sales, (K Doses), 2016-2021
Table 45. By Country - Middle East & Africa Influenza Vaccine Sales, (K Doses), 2022-2027
Table 46. CSL Corporate Summary
Table 47. CSL Influenza Vaccine Product Offerings
Table 48. CSL Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 49. GSK Corporate Summary
Table 50. GSK Influenza Vaccine Product Offerings
Table 51. GSK Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 52. Sanofi Pasteur Corporate Summary
Table 53. Sanofi Pasteur Influenza Vaccine Product Offerings
Table 54. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 55. Mylan Corporate Summary
Table 56. Mylan Influenza Vaccine Product Offerings
Table 57. Mylan Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Influenza Vaccine Product Offerings
Table 60. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Influenza Vaccine Product Offerings
Table 63. Pfizer Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 64. Johnson & Johnson Corporate Summary
Table 65. Johnson & Johnson Influenza Vaccine Product Offerings
Table 66. Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2016-2021)
Table 67. Influenza Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2019-2021 (K Doses)
Table 68. Global Influenza Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 69. Global Influenza Vaccine Production by Region, 2016-2021 (K Doses)
Table 70. Global Influenza Vaccine Production by Region, 2022-2027 (K Doses)
Table 71. Influenza Vaccine Market Opportunities & Trends in Global Market
Table 72. Influenza Vaccine Market Drivers in Global Market
Table 73. Influenza Vaccine Market Restraints in Global Market
Table 74. Influenza Vaccine Raw Materials
Table 75. Influenza Vaccine Raw Materials Suppliers in Global Market
Table 76. Typical Influenza Vaccine Downstream
Table 77. Influenza Vaccine Downstream Clients in Global Market
Table 78. Influenza Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Influenza Vaccine Segment by Type
Figure 2. Influenza Vaccine Segment by Application
Figure 3. Global Influenza Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Influenza Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Influenza Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Influenza Vaccine Sales in Global Market: 2016-2027 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Influenza Vaccine Revenue in 2020
Figure 9. By Type - Global Influenza Vaccine Sales Market Share, 2016-2027
Figure 10. By Type - Global Influenza Vaccine Revenue Market Share, 2016-2027
Figure 11. By Type - Global Influenza Vaccine Price (USD/Doses), 2016-2027
Figure 12. By Application - Global Influenza Vaccine Sales Market Share, 2016-2027
Figure 13. By Application - Global Influenza Vaccine Revenue Market Share, 2016-2027
Figure 14. By Application - Global Influenza Vaccine Price (USD/Doses), 2016-2027
Figure 15. By Region - Global Influenza Vaccine Sales Market Share, 2016-2027
Figure 16. By Region - Global Influenza Vaccine Revenue Market Share, 2016-2027
Figure 17. By Country - North America Influenza Vaccine Revenue Market Share, 2016-2027
Figure 18. By Country - North America Influenza Vaccine Sales Market Share, 2016-2027
Figure 19. US Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Influenza Vaccine Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Influenza Vaccine Sales Market Share, 2016-2027
Figure 24. Germany Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. France Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Influenza Vaccine Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Influenza Vaccine Sales Market Share, 2016-2027
Figure 33. China Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. India Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Influenza Vaccine Revenue Market Share, 2016-2027
Figure 39. By Country - South America Influenza Vaccine Sales Market Share, 2016-2027
Figure 40. Brazil Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Influenza Vaccine Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Influenza Vaccine Sales Market Share, 2016-2027
Figure 44. Turkey Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Influenza Vaccine Revenue, (US$, Mn), 2016-2027
Figure 48. Global Influenza Vaccine Production Capacity (K Doses), 2016-2027
Figure 49. The Percentage of Production Influenza Vaccine by Region, 2020 VS 2027
Figure 50. Influenza Vaccine Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs